Ahmad F - Search Results

1

SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states.

Banerjee SK, McGaffin KR, Pastor-Soler NM, Ahmad F. Banerjee SK, et al. Among authors: ahmad f. Cardiovasc Res. 2009 Oct 1;84(1):111-8. doi: 10.1093/cvr/cvp190. Epub 2009 Jun 9. Cardiovasc Res. 2009. PMID: 19509029 Free PMC article.

2

SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy.

Banerjee SK, Wang DW, Alzamora R, Huang XN, Pastor-Soler NM, Hallows KR, McGaffin KR, Ahmad F. Banerjee SK, et al. Among authors: ahmad f. J Mol Cell Cardiol. 2010 Oct;49(4):683-92. doi: 10.1016/j.yjmcc.2010.06.003. Epub 2010 Jun 20. J Mol Cell Cardiol. 2010. PMID: 20600102 Free PMC article.

3

Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation.

Banerjee SK, McGaffin KR, Huang XN, Ahmad F. Banerjee SK, et al. Among authors: ahmad f. Biochim Biophys Acta. 2010 Feb;1802(2):284-91. doi: 10.1016/j.bbadis.2009.12.001. Epub 2009 Dec 11. Biochim Biophys Acta. 2010. PMID: 20005292 Free article.

4

A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia.

Banerjee SK, Ramani R, Saba S, Rager J, Tian R, Mathier MA, Ahmad F. Banerjee SK, et al. Among authors: ahmad f. Biochem Biophys Res Commun. 2007 Aug 24;360(2):381-7. doi: 10.1016/j.bbrc.2007.06.067. Epub 2007 Jun 19. Biochem Biophys Res Commun. 2007. PMID: 17597581

5

The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy.

Ahmad F, Banerjee SK, Lage ML, Huang XN, Smith SH, Saba S, Rager J, Conner DA, Janczewski AM, Tobita K, Tinney JP, Moskowitz IP, Perez-Atayde AR, Keller BB, Mathier MA, Shroff SG, Seidman CE, Seidman JG. Ahmad F, et al. PLoS One. 2008 Jul 9;3(7):e2642. doi: 10.1371/journal.pone.0002642. PLoS One. 2008. PMID: 18612386 Free PMC article.

6

Cardiac sodium-dependent glucose cotransporter 1 is a novel mediator of ischaemia/reperfusion injury.

Li Z, Agrawal V, Ramratnam M, Sharma RK, D'Auria S, Sincoular A, Jakubiak M, Music ML, Kutschke WJ, Huang XN, Gifford L, Ahmad F. Li Z, et al. Among authors: ahmad f. Cardiovasc Res. 2019 Sep 1;115(11):1646-1658. doi: 10.1093/cvr/cvz037. Cardiovasc Res. 2019. PMID: 30715251 Free PMC article.

7

Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy with Calcium Desensitization.

Ramratnam M, Salama G, Sharma RK, Wang DW, Smith SH, Banerjee SK, Huang XN, Gifford LM, Pruce ML, Gabris BE, Saba S, Shroff SG, Ahmad F. Ramratnam M, et al. Among authors: ahmad f. PLoS One. 2016 Dec 9;11(12):e0167681. doi: 10.1371/journal.pone.0167681. eCollection 2016. PLoS One. 2016. PMID: 27936050 Free PMC article.

8

Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.

Ramratnam M, Sharma RK, D'Auria S, Lee SJ, Wang D, Huang XY, Ahmad F. Ramratnam M, et al. Among authors: ahmad f. J Am Heart Assoc. 2014 Aug 4;3(4):e000899. doi: 10.1161/JAHA.114.000899. J Am Heart Assoc. 2014. PMID: 25092788 Free PMC article.

9

The genetic basis for cardiac remodeling.

Ahmad F, Seidman JG, Seidman CE. Ahmad F, et al. Annu Rev Genomics Hum Genet. 2005;6:185-216. doi: 10.1146/annurev.genom.6.080604.162132. Annu Rev Genomics Hum Genet. 2005. PMID: 16124859 Review.

10

SGLT1 and Sweet Genetic Insights Into Cardiometabolic Risk.

Ahmad F, Li Z, Shibbani K. Ahmad F, et al. J Am Coll Cardiol. 2018 Oct 9;72(15):1774-1777. doi: 10.1016/j.jacc.2018.07.060. J Am Coll Cardiol. 2018. PMID: 30286919 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,714 results

Search Page